08 Dec Low Risk Prostate Cancer: Panel endorses active monitoring
Posted at 19:59h
in Prostate Cancer
An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression. However, monitoring strategies—such as active surveillance—have not been uniformly studied and available data do...